OWLT — Owlet, Inc.

Summary of Owlet (OWLT) Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 2025 Revenue: $26.6 million, up 29.6% year-over-year.
• Full Year 2025 Revenue: $105.7 million, a 35.4% increase from 2024.
• Q4 Gross Margin: 47.6%, impacted by tariffs (510 basis points).
• Full Year 2025 Gross Margin: Record high of 50.6%.
• Q4 Adjusted EBITDA: $0.1 million, down from $0.5 million in Q4 2024.
• Full Year 2025 Adjusted EBITDA: $2 million, a $3.8 million improvement over 2024.
• Cash Position: $35.5 million as of December 31, 2025, up from $23.8 million in Q3 2025.

2. Strategic Updates and Business Highlights

• Owlet360 Subscription Service: Launched in January 2025, now has over 110,000 paying subscribers, contributing to long-term customer relationships.
• Product Launches: Introduced the Dream Sight camera in September 2025, enhancing the product suite and expected to drive further subscription growth.
• International Expansion: Q4 international revenue reached $3.9 million, with significant growth in markets like the U.K. and France. Regulatory approvals in India and Israel are set to enhance future sales channels.
• Healthcare Partnerships: Expanded Medicaid coverage to 37 states and increased commercial insurance partnerships to 258, covering over 90% of U.S. births.
• Telehealth Initiative: Owlet OnCall platform expected to launch in the second half of 2026, leveraging real-time data from existing products to enhance pediatric care.

3. Forward Guidance and Outlook

• Q1 2026 Revenue Guidance: Expected between $20 million and $21 million, reflecting seasonality and a softer consumer spending environment.
• Full Year 2026 Revenue Guidance: Projected between $126 million and $130 million, representing 19% to 23% growth over 2025.
• Adjusted EBITDA for 2026: Expected between $3 million and $5 million, indicating a significant improvement over 2025.
• Gross Margin Expectations: Anticipated between 49% and 52% for the full year 2026, factoring in ongoing tariff impacts.

4. Bad News, Challenges, or Points of Concern

• Tariff Impact: Tariffs continue to affect gross margins, with an estimated 510 basis point impact expected to persist.
• Consumer Spending Softness: Noted a decline in consumer spending during Q4 2025, which may affect Q1 2026 performance.
• International Revenue Transition: A shift to a direct import model in the U.K. has delayed revenue recognition, pushing some sales into Q1 2026.
• FDA Communication: No new updates from the FDA regarding safety communications, although the company maintains a strong market position.

5. Notable Q&A Insights

• Q1 Revenue Guidance: Management acknowledged that Q1 is typically the weakest quarter due to seasonality and the impact of a strong prior year driven by health crises.
• AI Integration: Plans to leverage AI for personalized health insights and enhance the Owlet360 subscription, aiming to evolve from a hardware-centric to a data-driven platform.
• International Market Potential: Significant growth opportunities identified in international markets, particularly in India and Europe, with plans to expand subscription services.
• Telehealth Strategy: Owlet OnCall will be positioned as a premium add-on to the existing subscription, with a focus on enhancing care quality through real-time data sharing.

Overall, Owlet reported a strong performance in 2025, with strategic initiatives set to drive future growth, although challenges related to tariffs and consumer spending remain.